- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03962205
Promoting Weight Loss and Psychological Well-being in Obese Patients
Promoting Weight Loss and Psychological Well-being in Obese Patients: Combination of Behavioral Life Style and Well-Being Intervention
Study Overview
Status
Conditions
Detailed Description
The present study is a longitudinal, single blind, randomized controlled pilot trial. The participants will be recruited at the Center of Metabolism Diseases and Clinical Dietetics of Sant'Orsola Hospital in Bologna, directed by Prof. Giulio Marchesini Reggiani, after approval of the Ethics Committee of Azienda Ospedaliero-Universitaria of Bologna.
Patients attending the Center of Metabolism Diseases and Clinical Dietetics during the enrollment period will be screened for inclusion and exclusion criteria by care coordinators or clinicians. Eligible patients will be required to sign the informed consent form and the consent form for personal data processing. The researchers will be in charge of explaining the project to make sure that it is fully understood by the patients.
During the first 3 months, all the participants will undergo a behavioral program focusing on lifestyle modification. The participants who accomplish the program for life-style modification will be randomly assigned to either the control group or the experimental group. Generalized block randomization will be carried out by a computer program (the Random Allocation Software 2.0), with an allocation ratio of 1:1.
Participants in the experimental group will receive a four-session intervention on psychological well-being. Each session will last one hour and will be offered weekly, based on the principles of Well-Being Therapy. Patients in the control group will only receive a treatment as usual (TAU), according to the instructions given by their clinicians. Data will be collected for each participant through questionnaires and interviews at baseline, at the end of the life-style intervention, at the end of the well-being intervention, and at 6 months of follow-up after the intervention. Given the nature of this study, it will not be possible for participants and treatment delivers to be blinded. Trained researchers, masked to the experimental allocation of patients, will perform measurements and analyses of the data to minimize potential bias.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Emilia Romagna
-
Bologna, Emilia Romagna, Italy, 40138
- SSD Malattie del Metabolismo e Dietetica Clinica Policlinico Sant'Orsola- Malpighi
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- obese (BMI ≥ 30)
- aged ≥18 years
- willing to participate in the study.
Exclusion Criteria:
- inability to provide informed consent to participate in the study (i.e. psychotic or mentally impaired patients);
- insufficient knowledge of Italian;
- presence of a medical condition associated with unintentional weight loss or gain;
- presence of major psychiatric illness and cognitive deficit;
- participation in another weight-loss program;
- use of medication for weight loss;
- history of weight loss surgery or weight loss surgery scheduled during the last year or within 16 months from the beginning of the study;
- being pregnant or intended pregnancy during the last year or within 16 months from the beginning of the study.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Cognitive Behavioral life-style and well-being intervention
Participants will receive 12 group-based 2-hour weekly sessions for life-style modification and then 4 group-based 2-hour weekly sessions of the well-being intervention in addition to the treatment as usual.
|
Cognitive Behavioral life-style modification: The intervention will be composed of 12 weekly sessions.
Each session will last about two hours and will be administered in a group setting (maximum 20 participants).
During the first two sessions, a clinician will introduce the program to the participants and motivate them to make life-style changes.In the next eight sessions a dietician will provide participants with basics of nutrition and will coach them to use a structured diary to monitor their eating behavior and physical activity.
Next, a physician will introduce to the patients various weight loss surgeries in terms of the adverse events, indications and effects of each option.The last session will be held by a psychologist and will focus on providing participants with useful strategies to promote healthy eating habits and physical activity, including problem solving and goal setting.
This program will consist of 4 weekly group-based sessions and each meeting will last about two hours.
During the sessions, participants will be coached how to self-monitor their well-being episodes in everyday life, especially those associated with life-style change, by means of a structured diary.
Patients will be then ecounraged to discuss their well-being experiences during group sessions, focusing on dysfunctional thoughts/beliefs interrupting them, fostering the identification of more functional thoughts.
The psychologist will also teach them how to promote well-being situations through behavioral exercises and will introduce to the participants relevant psychological well-being dimensions (based on Carol Ryff's multidimensional model) associated with patients' experiences emerged during the treatment.
The treatment as usual will involve any recommendation given to the participants by their physicians, including diet, physical activity and medication.
|
Placebo Comparator: Cognitive Behavioral life-style intervention
Participants will receive 12 group-based 2-hour weekly sessions for life-style modification in addition to the treatment as usual.
|
Cognitive Behavioral life-style modification: The intervention will be composed of 12 weekly sessions.
Each session will last about two hours and will be administered in a group setting (maximum 20 participants).
During the first two sessions, a clinician will introduce the program to the participants and motivate them to make life-style changes.In the next eight sessions a dietician will provide participants with basics of nutrition and will coach them to use a structured diary to monitor their eating behavior and physical activity.
Next, a physician will introduce to the patients various weight loss surgeries in terms of the adverse events, indications and effects of each option.The last session will be held by a psychologist and will focus on providing participants with useful strategies to promote healthy eating habits and physical activity, including problem solving and goal setting.
The treatment as usual will involve any recommendation given to the participants by their physicians, including diet, physical activity and medication.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
4-month Change in body weight in kg
Time Frame: Baseline, 4 months
|
4-month average change in body weight (kg) from baseline to 4 months.
Weight will be measured with a standard balance beam scale with the participant in a lightweight clothing.
|
Baseline, 4 months
|
4-month Change in body weight in %
Time Frame: Baseline, 4 months
|
4-month average change in body weight as a percentage of start weight
|
Baseline, 4 months
|
10-month change in body weight in kg
Time Frame: Baseline, 10 months
|
10-month average change in body weight (kg) from baseline to 10 months.
|
Baseline, 10 months
|
10-month change in body weight in %
Time Frame: Baseline, 10 months
|
10-month average change in body weight as a percentage of start weight
|
Baseline, 10 months
|
16-month change in body weight in kg
Time Frame: Baseline, 16 months
|
16-month average change in body weight (kg)
|
Baseline, 16 months
|
16-month change in body weight in %
Time Frame: Baseline, 16 months
|
16-month average change in body weight as a percentage of start weight
|
Baseline, 16 months
|
Change in Body mass Index (BMI)
Time Frame: Baseline, 4 months,10 months,16 months
|
It will be computed as body weight (kg) divided by the square of height (m²).
|
Baseline, 4 months,10 months,16 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in psychological well-being
Time Frame: Baseline, 4 months,10 months,16 months
|
It will be measured with the Psychological WellBeing scale, a 42-item self-rating scale, which includes six dimensions: self-acceptance, positive relations with others, autonomy, environmental mastery, purpose in life and personal growth.
The respondents are asked to indicate on a 6-likert scale the extent to which they agree with each statement.
Each dimension may range from 7-42, with higher scores indicating greater psychological well-being.
|
Baseline, 4 months,10 months,16 months
|
Change in the prevalence of depression
Time Frame: Baseline, 4 months,10 months,16 months
|
It will be measured by well-trained researcher with The Structured Clinical Interview for Diagnostic and Statistical Manual of Mental Disorders - 5th edition (SCID-5-CV).
|
Baseline, 4 months,10 months,16 months
|
Change in the prevalence of demoralization
Time Frame: Baseline, 4 months,10 months,16 months
|
It will be measured by well-trained researchers with The Diagnostic Criteria for Psychosomatic Research-Revised Semi-Structured Interview- Revised (DCPR-R)
|
Baseline, 4 months,10 months,16 months
|
Change in psychological distress
Time Frame: Baseline, 4 months,10 months,16 months
|
It will be measured by the Symptom Questionnaire (SQ), a 92-item self-rating instrument with dichotomous responses divided into 4 dimensions: depression, anxiety, somatization and hostility/irritability.
Each dimension consists in a symptom sub-scale including 17 questions and a well being one with 6 questions.
Scores may range from 0 to 17 for each symptom sub-scale and from 0 to 6 for each well-being sub-scale.
For each dimension, higher scores indicate more severe psychological distress.
|
Baseline, 4 months,10 months,16 months
|
Change in lifestyle
Time Frame: Baseline, 4 months,10 months,16 months
|
It will be measured with GOSPEL (GlObal Secondary Prevention strategiEs to Limit event recurrence after myocardial infarction - GOSPEL study) questionnaire, a 32-item self-rating instrument for the assessment of physical activity levels, eating habits, and stress levels used among patients who need to change their lifestyle. The subscale on physical activity includes eight 4-point items with a total score ranging from 0 (poor/absent physical activity) to 20 (very high physical activity). The subscale on eating habits consists of ten 4-point items regarding Mediterranean diet based on the frequency of healthy food consumption, with a total score ranging from 0 (worst) to 30 (best). Three additional 4-point items on eating behavior are also included: their total score may range from 0 (bad dietary behavior) to 9 (healthy dietary behavior). The subscale on stress management includes seven 4-point items which total score may range from 0 (inadequate) to 21 (optimal). |
Baseline, 4 months,10 months,16 months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in psychosocial profile
Time Frame: Baseline, 4 months,10 months,16 months
|
It will be measured with the PsychoSocial Index (PSI).
PSI is a 55-item self-rating scale, divided into 5 domains: 1) Sociodemographic and clinical data (12 questions on medical and demographic information); 2) Stress subscale (17 yes/no questions) with a score ranging from 0 to 17 (a higher score indicates greater stress); 3) Well-being subscale (6 yes/no questions) with a score ranging from 0 to 6 (a higher score indicates greater psychological well-being); 4) Psychological distress (15 four-point questions ranging from 0 to 3) with a total score from 0 to 45 (a higher score indicates greater psychological distress); 5) Abnormal Illness Behavior (3 four-point questions from 0 to 3) with a total score ranging from 0 to 9 (a higher score indicates more severe abnormal illness behavior).
Finally, PSI includes one 4-point question on self-perceived quality of life, with a score from 0 to 4 (a higher score indicates better quality of life).
|
Baseline, 4 months,10 months,16 months
|
Change in motivation for weight change
Time Frame: Baseline, 4 months,10 months,16 months
|
It will be measured by the Goal Related Weight Questionnaire (GRWQ), which asks the respondents to self-report their dream, happy, acceptable, and disappointed weight in kilograms in the first part (4 items) and to indicate to which extent they expect weight loss to impact various aspects of their psycho-social and health-related functioning, with each item scored from 1 (extremely negative) to 10 (extremely positive), in the second part (21 items).
|
Baseline, 4 months,10 months,16 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Study Director: Chiara Rafanelli, MD,PhD, University of Bologna
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- PWlPwb-OB
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Central Hospital, Nancy, FranceNot yet recruiting
-
University of MinnesotaNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Active, not recruitingAdolescent ObesityUnited States
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsActive, not recruitingOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Fundació Sant Joan de DéuRecruitingObesity, Childhood | Obesity, AdolescentSpain
Clinical Trials on cognitive-behavioral life style intervention
-
Finnish Institute for Health and WelfareAcademy of FinlandCompleted
-
Mayo ClinicJames and Esther King Biomedical Research ProgramCompletedfor Cigarette Smoking and Binge Drinking CessationUnited States
-
University of Rochester NCORP Research BaseNational Cancer Institute (NCI)CompletedInsomnia | Cancer Survivor | Malignant NeoplasmUnited States
-
Glostrup University Hospital, CopenhagenLundbeck Foundation; Sygekassernes HelsefondCompletedPhysical Activity | Sedentary Behavior | Life StyleDenmark
-
Emirates Health Services (EHS)Mayo ClinicCompletedObesity | Non-Alcoholic Fatty Liver DiseaseUnited Arab Emirates
-
Isfahan University of Medical SciencesCompletedDiabetes Mellitus, Type 2Iran, Islamic Republic of
-
Tzu-Ting HuangCompletedPhysical Activity | Mild Cognitive Impairment | Cognitive Rehabilitation | TTM
-
The George InstituteNational Health and Medical Research Council, Australia; All India Institute...CompletedGestational Diabetes Mellitus in PregnancyBangladesh, India, Sri Lanka
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI); National Heart, Lung, and Blood Institute...Active, not recruitingHealthy SubjectUnited States
-
M.D. Anderson Cancer CenterRecruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States